Daniel Stauder
Stock Analyst at Citizens
(3.93)
# 495
Out of 5,058 analysts
20
Total ratings
52.63%
Success rate
13.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Market Outperform | $47 → $53 | $44.63 | +18.75% | 7 | Nov 7, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $34.19 | +75.52% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $1.49 | +369.80% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $86.95 | +26.51% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $531.09 | +36.51% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $11.23 | - | 1 | May 7, 2024 |
Artivion
Nov 7, 2025
Maintains: Market Outperform
Price Target: $47 → $53
Current: $44.63
Upside: +18.75%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $34.19
Upside: +75.52%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $1.49
Upside: +369.80%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $86.95
Upside: +26.51%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $531.09
Upside: +36.51%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $11.23
Upside: -